Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 10Wound Infection 1Urologic Diseases 1Urinary Tract Infections 1Urinary Bladder Diseases 1Ureteral Neoplasms 1Recurrence 1Neoplasms 1Muscle Invasive Bladder Cancer 1Infections 1Disease Progression 1Cross Infection 1Carcinoma, Transitional Cell 1Bacterial Infections 1

Interventions

Cyclophosphamide 21venetoclax 18pembrolizumab 16Dexamethasone 16fludarabine 14Cytarabine 13Gemcitabine 9pomalidomide 8Rituximab 8Carboplatin 8Azacitidine 8glofitamab 7fludarabine phosphate 7Lenalidomide 7Immunotherapy, Adoptive 7selinexor 6Paclitaxel 6Injections 6Granulocyte Colony-Stimulating Factor 6Cisplatin 6daratumumab 5Temozolomide 5Oxaliplatin 5Bevacizumab 5zanubrutinib 4ruxolitinib 4Surgical Procedures, Operative 4Nivolumab 4Drug Therapy 4Decitabine 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Recurrence × Cystectomy × Clear all
NCT04900558 2021-05-25

Robotic Radical Cystectomy Outcomes

University of Florence

Recruiting
500 enrolled
Genitourinary

Urinary Bladder Neoplasms, Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡